Department of Surgery, University of Illinois, Mount Sinai Hospital, Chicago, IL 60637, USA.
Ann Thorac Surg. 2012 Oct;94(4):1086-92. doi: 10.1016/j.athoracsur.2012.05.102. Epub 2012 Aug 24.
Malignant pleural mesothelioma is an aggressive malignancy in which radical surgical treatment appears to improve survival. It is unknown, however, if radical surgical treatment affects quality of life (QoL) adversely. Our objective was to assess patient-reported symptoms of health-related QoL after radical pleurectomy decortication (PD).
Patients with malignant pleural mesothelioma were prospectively enrolled between 2010 and 2011 to determine the effects of PD on baseline QoL. Health-related QoL was assessed using the European Organization for Research and Treatment of Cancer core Quality of Life Questionnaire-C30 tool (EORTC QLQ-C30) before operation and at 1, 5 to 6, and 8 to 9 months postoperatively. Patients were grouped based on World Health Organization baseline performance status (PS) and compared.
Of the 28 patients enrolled, 16 (57.1%) and 12 (42.9%) were World Health Organization PS 0 and PS 1, respectively. At baseline, PS 1 patients had significantly worse global QoL functional and symptom scores at baseline. At 5 to 6 months' follow-up, PS 0 patients had no significant change in global QoL or functional domain scores. PS 1 patients had significant improvement in global QoL (p=0.038), symptoms of fatigue (p=0.05), and dyspnea (p=0.048). At 8 to 9 months' follow-up, PS 0 patients showed significant improvement in symptoms of fatigue (p=0.026) from baseline and PS 1 maintained the improvements in symptoms of fatigue (p=0.049) and dyspnea (p=0.048).
Radical PD does not negatively impact minimally symptomatic patients at intermediate follow-up. Patients who have symptoms at baseline can have significant improvement in their QoL after surgical treatment.
恶性胸膜间皮瘤是一种侵袭性恶性肿瘤,根治性手术治疗似乎可以提高生存率。然而,目前尚不清楚根治性手术治疗是否会对生活质量(QoL)产生不利影响。我们的目的是评估根治性胸膜剥脱术(PD)后患者报告的健康相关 QoL 症状。
2010 年至 2011 年期间,前瞻性纳入患有恶性胸膜间皮瘤的患者,以确定 PD 对基线 QoL 的影响。使用欧洲癌症研究与治疗组织核心生活质量问卷-C30 工具(EORTC QLQ-C30)在术前和术后 1、5 至 6 个月和 8 至 9 个月评估健康相关 QoL。根据世界卫生组织(WHO)基线表现状态(PS)对患者进行分组并进行比较。
在纳入的 28 例患者中,16 例(57.1%)和 12 例(42.9%)分别为 WHO PS 0 和 PS 1。基线时,PS 1 患者的整体 QoL 功能和症状评分明显较差。在 5 至 6 个月的随访中,PS 0 患者的整体 QoL 或功能域评分无显著变化。PS 1 患者的整体 QoL 有显著改善(p=0.038),疲劳症状(p=0.05)和呼吸困难(p=0.048)也有显著改善。在 8 至 9 个月的随访中,PS 0 患者的疲劳症状从基线开始有显著改善(p=0.026),PS 1 患者的疲劳症状(p=0.049)和呼吸困难症状(p=0.048)保持改善。
在中期随访中,根治性 PD 不会对症状轻微的患者产生负面影响。基线时有症状的患者在接受手术治疗后,其 QoL 可能会显著改善。